HCPLive Network

HIV-Risk Behaviors Stable for U.S. High School Students

Wednesday, July 25 (HealthDay News) -- Using data from the CDC's National Youth Risk Behavior Surveys from 1991 to 2001, Laura Kann, Ph.D., from the CDC in Atlanta, and colleagues examined trends overall and by race/ethnicity for HIV-related risk behavior among U.S. high school students.

The researchers found that, through the early 2000s, sexual risk behaviors declined among U.S. high school students, but progress subsequently stalled. From 1991 to 2001 there was a decrease in the proportion of U.S. high school students who had ever had sex (54 to 46 percent) or had had multiple partners (four or more; 19 to 14 percent); there was an increase in the proportion of students who used a condom last time they had sex (from 46 percent in 1991 to 63 percent in 2003). These proportions stabilized and were 47, 15, and 60 percent, respectively, in 2011. There was also a decrease in the proportion of students who had had sex within the preceding three months, from 38 percent in 1991 to 34 percent in 2011.

"Protecting the health of young people and accelerating progress in HIV prevention in this population will require building upon these and other efforts in homes, schools, and communities across the nation," the authors write. "Only by intensifying our collective efforts will we be able to achieve our shared goal of an AIDS-free generation."

Full Text
More Information

Although there were reductions in HIV-related risk behavior among U.S high school students from 1991 to the early 2000s, behaviors have subsequently stabilized, according to research published in the June 24 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report to coincide with the International AIDS Conference, held from July 22 to 27 in Washington, D.C.

Copyright © 2012 HealthDay. All rights reserved.


Further Reading
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
The costs of Medicare associated with Sovaldi (sofosbuvir), an emerging hepatitis C drug, will vary depending on how many people are given the treatment, a blog in Health Affairs found.
The European Commission (EU) has granted Bristol-Myers Squibb’s Daklinza (daclatasvir) approval for an all-oral drug regimen for the treatment of four genotypes of chronic hepatitis C infection.
While the US Preventive Services Task Force does not recommend screening for hepatitis B virus infection in asymptomatic persons in the general population, a recent update focuses on identifying those who are high risk and should be screened.
The Ebola outbreak in West Africa continues to expand and around the world researchers are striving to learn more about the disease and how to stop it to ensure that any future outbreaks of the virus are not nearly as severe.
More than 90% of children 19 to 35 months of age are getting the vaccines that prevent measles, mumps, and rubella; polio; hepatitis B; and varicella, according to the US Centers for Disease Control and Prevention. The new findings were published in the Aug. 29 issue of the CDC's Morbidity and Mortality Weekly Report.
The deadly Ebola outbreak hitting 4 West African nations could eventually infect more than 20,000 people, the World Health Organization announced Thursday.

More Reading